Lamendola C - Search Results

1

American Heart Association Diabetes and Cardiometabolic Health Summit: Summary and Recommendations.

Sasson C, Eckel R, Alger H, Bozkurt B, Carson A, Daviglus M, Deedwania P, Kirley K, Lamendola C, Nguyen M, Rajgopal Singh R, Wang T, Sanchez E. Sasson C, et al. Among authors: lamendola c. J Am Heart Assoc. 2018 Aug 7;7(15):e009271. doi: 10.1161/JAHA.118.009271. J Am Heart Assoc. 2018. PMID: 30371251 Free PMC article. No abstract available.

2

High carbohydrate diets, triglyceride-rich lipoproteins, and coronary heart disease risk.

Abbasi F, McLaughlin T, Lamendola C, Kim HS, Tanaka A, Wang T, Nakajima K, Reaven GM. Abbasi F, et al. Among authors: lamendola c. Am J Cardiol. 2000 Jan 1;85(1):45-8. doi: 10.1016/s0002-9149(99)00604-9. Am J Cardiol. 2000. PMID: 11078235 Free article. Clinical Trial.

3

Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers.

Abbasi F, McLaughlin T, Lamendola C, Yeni-Komshian H, Tanaka A, Wang T, Nakajima K, Reaven GM. Abbasi F, et al. Among authors: lamendola c. J Clin Endocrinol Metab. 1999 Nov;84(11):3903-6. doi: 10.1210/jcem.84.11.6136. J Clin Endocrinol Metab. 1999. PMID: 10566626

4

Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus.

Abbasi F, Asagmi T, Cooke JP, Lamendola C, McLaughlin T, Reaven GM, Stuehlinger M, Tsao PS. Abbasi F, et al. Among authors: lamendola c. Am J Cardiol. 2001 Nov 15;88(10):1201-3. doi: 10.1016/s0002-9149(01)02063-x. Am J Cardiol. 2001. PMID: 11703973 No abstract available.

5

Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus.

Abbasi F, Chu JW, McLaughlin T, Lamendola C, Leary ET, Reaven GM. Abbasi F, et al. Among authors: lamendola c. Metabolism. 2004 Feb;53(2):159-64. doi: 10.1016/j.metabol.2003.07.020. Metabolism. 2004. PMID: 14767866 Clinical Trial.

6

Lipoprotein risk factors for cardiovascular disease in patients with type 2 diabetes mellitus treated with oral antihyperglycaemic agents.

Chu JW, Abbasi F, McLaughlin TL, Lamendola C, Schaaf P, Carlson TH, Leary ET, Reaven GM. Chu JW, et al. Among authors: lamendola c. Diabetes Obes Metab. 2003 Sep;5(5):333-7. doi: 10.1046/j.1463-1326.2003.00284.x. Diabetes Obes Metab. 2003. PMID: 12940871

7

Use of metabolic markers to identify overweight individuals who are insulin resistant.

McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. McLaughlin T, et al. Among authors: lamendola c. Ann Intern Med. 2003 Nov 18;139(10):802-9. doi: 10.7326/0003-4819-139-10-200311180-00007. Ann Intern Med. 2003. PMID: 14623617

8

Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes.

Asagami T, Abbasi F, Stuelinger M, Lamendola C, McLaughlin T, Cooke JP, Reaven GM, Tsao PS. Asagami T, et al. Among authors: lamendola c. Metabolism. 2002 Jul;51(7):843-6. doi: 10.1053/meta.2002.33349. Metabolism. 2002. PMID: 12077728 Clinical Trial.

9

Relationship between obesity, insulin resistance, and coronary heart disease risk.

Abbasi F, Brown BW Jr, Lamendola C, McLaughlin T, Reaven GM. Abbasi F, et al. Among authors: lamendola c. J Am Coll Cardiol. 2002 Sep 4;40(5):937-43. doi: 10.1016/s0735-1097(02)02051-x. J Am Coll Cardiol. 2002. PMID: 12225719 Free article.

10

Early and more vigorous detection of diabetes.

Lamendola C. Lamendola C. J Cardiovasc Nurs. 2003 Apr-Jun;18(2):103-7. doi: 10.1097/00005082-200304000-00005. J Cardiovasc Nurs. 2003. PMID: 12680568 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters